Allarity Therapeutics Terminates $6 Million Stock Purchase Agreement

Allarity Therapeutics terminated its common stock purchase agreement with Tumim Stone Capital on October 28, 2026. The agreement allowed the company to sell up to $6.0 million of common stock at its discretion; no early termination penalty is payable.